Global Artificial Intelligence in Diagnostics Market Research Report 2024

Publication ID:

PB506242206

Publication Date:

June 11, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The implementation of artificial intelligence (AI) technology in medical diagnostic devices and systems has changed the way patients are treated and diagnosed in the healthcare industry.Artificial intelligence is mainly used in medical institutions to check the correlation between treatment procedures and patient prognosis.After successful deployment and success, AI technology is likely to be widely used in medical practice, including medical imaging, drug development, personalized medicine and patient monitoring and care.The use of AI technology and machine learning in diagnostics can strengthen the growth of the global market by improving patient safety to improve diagnostic accuracy and reduce costs.
The global Artificial Intelligence in Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence in Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in Diagnostics.
Report Scope
The Artificial Intelligence in Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence in Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence in Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aidoc Medical
AliveCor
GE Healthcare
Siemens Healthineers AG
Imagen Technologies锛孖nc
Vuno Inc
IDx Technologies Inc
NovaSignal Corporation
Riverain Technologies
Zebra Medical Vision
OSPLabs
Philips
Segment by Type
Software
Hardware
Services
Segment by Application
Cardiology
Oncology
Pathology
Radiology
Chest and Lung
Neurology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence in Diagnostics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence in Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Software
1.2.3 Hardware
1.2.4 Services
1.3 Market by Application
1.3.1 Global Artificial Intelligence in Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cardiology
1.3.3 Oncology
1.3.4 Pathology
1.3.5 Radiology
1.3.6 Chest and Lung
1.3.7 Neurology
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence in Diagnostics Market Perspective (2019-2030)
2.2 Artificial Intelligence in Diagnostics Growth Trends by Region
2.2.1 Global Artificial Intelligence in Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence in Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence in Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence in Diagnostics Market Dynamics
2.3.1 Artificial Intelligence in Diagnostics Industry Trends
2.3.2 Artificial Intelligence in Diagnostics Market Drivers
2.3.3 Artificial Intelligence in Diagnostics Market Challenges
2.3.4 Artificial Intelligence in Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence in Diagnostics Players by Revenue
3.1.1 Global Top Artificial Intelligence in Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence in Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence in Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence in Diagnostics Revenue
3.4 Global Artificial Intelligence in Diagnostics Market Concentration Ratio
3.4.1 Global Artificial Intelligence in Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Diagnostics Revenue in 2023
3.5 Artificial Intelligence in Diagnostics Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence in Diagnostics Product Solution and Service
3.7 Date of Enter into Artificial Intelligence in Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence in Diagnostics Breakdown Data by Type
4.1 Global Artificial Intelligence in Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence in Diagnostics Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence in Diagnostics Breakdown Data by Application
5.1 Global Artificial Intelligence in Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence in Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence in Diagnostics Market Size (2019-2030)
6.2 North America Artificial Intelligence in Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence in Diagnostics Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence in Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence in Diagnostics Market Size (2019-2030)
7.2 Europe Artificial Intelligence in Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence in Diagnostics Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence in Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence in Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence in Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence in Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence in Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence in Diagnostics Market Size (2019-2030)
9.2 Latin America Artificial Intelligence in Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence in Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence in Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence in Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence in Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence in Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence in Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aidoc Medical
11.1.1 Aidoc Medical Company Detail
11.1.2 Aidoc Medical Business Overview
11.1.3 Aidoc Medical Artificial Intelligence in Diagnostics Introduction
11.1.4 Aidoc Medical Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.1.5 Aidoc Medical Recent Development
11.2 AliveCor
11.2.1 AliveCor Company Detail
11.2.2 AliveCor Business Overview
11.2.3 AliveCor Artificial Intelligence in Diagnostics Introduction
11.2.4 AliveCor Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.2.5 AliveCor Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Artificial Intelligence in Diagnostics Introduction
11.3.4 GE Healthcare Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.3.5 GE Healthcare Recent Development
11.4 Siemens Healthineers AG
11.4.1 Siemens Healthineers AG Company Detail
11.4.2 Siemens Healthineers AG Business Overview
11.4.3 Siemens Healthineers AG Artificial Intelligence in Diagnostics Introduction
11.4.4 Siemens Healthineers AG Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.4.5 Siemens Healthineers AG Recent Development
11.5 Imagen Technologies锛孖nc
11.5.1 Imagen Technologies锛孖nc Company Detail
11.5.2 Imagen Technologies锛孖nc Business Overview
11.5.3 Imagen Technologies锛孖nc Artificial Intelligence in Diagnostics Introduction
11.5.4 Imagen Technologies锛孖nc Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.5.5 Imagen Technologies锛孖nc Recent Development
11.6 Vuno Inc
11.6.1 Vuno Inc Company Detail
11.6.2 Vuno Inc Business Overview
11.6.3 Vuno Inc Artificial Intelligence in Diagnostics Introduction
11.6.4 Vuno Inc Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.6.5 Vuno Inc Recent Development
11.7 IDx Technologies Inc
11.7.1 IDx Technologies Inc Company Detail
11.7.2 IDx Technologies Inc Business Overview
11.7.3 IDx Technologies Inc Artificial Intelligence in Diagnostics Introduction
11.7.4 IDx Technologies Inc Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.7.5 IDx Technologies Inc Recent Development
11.8 NovaSignal Corporation
11.8.1 NovaSignal Corporation Company Detail
11.8.2 NovaSignal Corporation Business Overview
11.8.3 NovaSignal Corporation Artificial Intelligence in Diagnostics Introduction
11.8.4 NovaSignal Corporation Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.8.5 NovaSignal Corporation Recent Development
11.9 Riverain Technologies
11.9.1 Riverain Technologies Company Detail
11.9.2 Riverain Technologies Business Overview
11.9.3 Riverain Technologies Artificial Intelligence in Diagnostics Introduction
11.9.4 Riverain Technologies Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.9.5 Riverain Technologies Recent Development
11.10 Zebra Medical Vision
11.10.1 Zebra Medical Vision Company Detail
11.10.2 Zebra Medical Vision Business Overview
11.10.3 Zebra Medical Vision Artificial Intelligence in Diagnostics Introduction
11.10.4 Zebra Medical Vision Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.10.5 Zebra Medical Vision Recent Development
11.11 OSPLabs
11.11.1 OSPLabs Company Detail
11.11.2 OSPLabs Business Overview
11.11.3 OSPLabs Artificial Intelligence in Diagnostics Introduction
11.11.4 OSPLabs Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.11.5 OSPLabs Recent Development
11.12 Philips
11.12.1 Philips Company Detail
11.12.2 Philips Business Overview
11.12.3 Philips Artificial Intelligence in Diagnostics Introduction
11.12.4 Philips Revenue in Artificial Intelligence in Diagnostics Business (2019-2024)
11.12.5 Philips Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Aidoc Medical
AliveCor
GE Healthcare
Siemens Healthineers AG
Imagen Technologies锛孖nc
Vuno Inc
IDx Technologies Inc
NovaSignal Corporation
Riverain Technologies
Zebra Medical Vision
OSPLabs
Philips

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂